EURONEXT-PAR$NBTX
Nanobiotix SA · Q4 2024 earnings
Q4 2024 earnings · · Investor relations
Reports awaiting report
Nanobiotix SA hasn't published Q4 2024 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q2 2024
- Revenue
- $9.29M
- EPS
- -$0.46
FY2024 consensus Analyst consensus
- Revenue
- $22.7M
- EPS
- -$1.05
Revenue & EPS history
Nanobiotix SA · Revenue · Quarterly
$9.29M
Q2 2024+182.1%vs Q2 2023
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q4 2024
-2.5%
Avg return
Earnings day
-8.7%
Avg return
5 days after
+9.1%
Avg return
30 days after
63%
5 / 8 earnings
Positive
+6.4%
Q2 2024
Best reaction
-31.3%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | — | — | — | |
| Q2 2024 | +6.4% | -1.4% | -5.4% | |
| Q4 2024 | +3.5% | +1.8% | +15.6% | |
| Q2 2023 | -1.5% | -4.2% | +48.6% | |
| Q4 2022 | -31.3% | -42.8% | +33.4% | |
| Q2 2022 | -5.9% | -4.6% | +7.0% | |
| Q4 2021 | +3.8% | -5.7% | -15.5% | |
| Q2 2021 | +0.8% | -3.8% | +3.2% | |
| Q4 2020 | +4.6% | -9.2% | -14.2% | |
| Q2 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q4 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q4 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q2 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro